Novartis, Biogen Scrap Gene Regulation Partnerships with Sangamo

cafead

Administrator
Staff member
  • cafead   Mar 20, 2023 at 09:53: AM
via Sangamo Therapeutics lost two powerhouse partners Friday after it reported that both Novartis and Biogen discontinued their partnerships studying gene regulation therapies in the neurology space.

article source